RxDoctor Payments Data

Thomas Davis

Clinical Pathology/Laboratory Medicine · Indianapolis, INNPI 1407809676

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Bard Peripheral Vascular, Inc..

$54in general payments, 2019–2025

Across 1 payment — averaging $53.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$54
$4,332,639in research payments, 2019–2025

Across 328 payments — averaging $13,209 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biomerieux Inc$1.2M
  • Abbott$847K
  • BD$646K
  • Roche Molecular Systems, Inc.$346K
  • Biofire Diagnostics, LLC$327K
  • Roche Diagnostics Corporation$268K
  • plus $715K from 7 others

What the payments were for

  • Food & beverage$54100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bard Peripheral Vascular, Inc.1$54

How this compares

Too few clinical pathology/laboratory medicine providers in Indianato place this figure against a meaningful peer group, so we don't.

Other clinical pathology/laboratory medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →